15-62067714-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_207322.3(C2CD4A):c.101C>T(p.Thr34Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000255 in 1,610,846 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_207322.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152212Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000450 AC: 11AN: 244182Hom.: 0 AF XY: 0.0000300 AC XY: 4AN XY: 133348
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1458634Hom.: 0 Cov.: 31 AF XY: 0.0000124 AC XY: 9AN XY: 725806
GnomAD4 genome AF: 0.000131 AC: 20AN: 152212Hom.: 0 Cov.: 33 AF XY: 0.0000672 AC XY: 5AN XY: 74356
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.101C>T (p.T34I) alteration is located in exon 2 (coding exon 1) of the C2CD4A gene. This alteration results from a C to T substitution at nucleotide position 101, causing the threonine (T) at amino acid position 34 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at